Artist 1

Trial description
A Randomized Phase 3 Study of AM0010 in Combination with FOLFOX Compared with FOLFOX Alone as Second-line Therapy in Patients with Metastatic Pancreatic Cancer that has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Contact name
Dr Pippa Corrie
Trial start date
Friday, July 21, 2017
Trial end date
Monday, December 30, 2019
Trial tumour type
Show on Radiotherapy